116 related articles for article (PubMed ID: 9016233)
1. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
[TBL] [Abstract][Full Text] [Related]
2. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.
Habel LA; Achacoso NS; Haque R; Nekhlyudov L; Fletcher SW; Schnitt SJ; Collins LC; Geiger AM; Puligandla B; Acton L; Quesenberry CP
Breast Cancer Res; 2009; 11(6):R85. PubMed ID: 19922614
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
J Am Coll Radiol; 2018 Mar; 15(3 Pt B):527-534. PubMed ID: 29398498
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of ductal carcinoma in situ.
Kerlikowske K
J Natl Cancer Inst Monogr; 2010; 2010(41):139-41. PubMed ID: 20956818
[TBL] [Abstract][Full Text] [Related]
5. Mammography of suspicious calcifications among ductal carcinoma in situ and benign breast disease.
Lohitvisate W; Kaeorat C; Kwankua A
SA J Radiol; 2024; 28(1):2852. PubMed ID: 38840823
[TBL] [Abstract][Full Text] [Related]
6. Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival.
Lång K; Sturesdotter L; Bengtsson Y; Larsson AM; Sartor H
Breast; 2024 Jun; 75():103736. PubMed ID: 38663074
[TBL] [Abstract][Full Text] [Related]
7. Pattern of breast diseases in Accra: review of mammography reports.
Brakohiapa EK; Armah GE; Clegg-Lamptey JN; Brakohiapa WO
Ghana Med J; 2013 Sep; 47(3):101-6. PubMed ID: 24391224
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for breast imaging follow-up of women with a previous history of breast cancer: position paper from the Italian Group for Mammography Screening (GISMa) and the Italian College of Breast Radiologists (ICBR) by SIRM.
Bucchi L; Belli P; Benelli E; Bernardi D; Brancato B; Calabrese M; Carbonaro LA; Caumo F; Cavallo-Marincola B; Clauser P; Fedato C; Frigerio A; Galli V; Giordano L; Golinelli P; Mariscotti G; Martincich L; Montemezzi S; Morrone D; Naldoni C; Paduos A; Panizza P; Pediconi F; Querci F; Rizzo A; Saguatti G; Tagliafico A; Trimboli RM; Zuiani C; Sardanelli F
Radiol Med; 2016 Dec; 121(12):891-896. PubMed ID: 27601142
[TBL] [Abstract][Full Text] [Related]
9. Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study.
Strell C; Smith DR; Valachis A; Woldeyesus H; Wadsten C; Micke P; Fredriksson I; Schiza A
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38763971
[TBL] [Abstract][Full Text] [Related]
10. The role of preoperative bilateral breast magnetic resonance imaging in patient selection for partial breast irradiation in ductal carcinoma in situ.
Kowalchik KV; Vallow LA; McDonough M; Thomas CS; Heckman MG; Peterson JL; Adkisson CD; Serago C; Buskirk SJ; McLaughlin SA
Int J Surg Oncol; 2012; 2012():206342. PubMed ID: 22655183
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.
Liu Y; Pérez M; Aft RL; Massman K; Robinson E; Myles S; Schootman M; Gillanders WE; Jeffe DB
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):675-80. PubMed ID: 20160274
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ within a fibroadenoma: A case report and review of literature.
Olivares-Antúnez Y; Dávila-Zablah YJ; Vázquez-Ávila JR; Gómez-Macías GS; Mireles-Aguilar MT; Garza-Montemayor ML
World J Radiol; 2024 Mar; 16(3):58-68. PubMed ID: 38596169
[TBL] [Abstract][Full Text] [Related]
13. Tools to Guide Radiation Oncologists in the Management of DCIS.
Leonardi MC; Zerella MA; Lazzeroni M; Fusco N; Veronesi P; Galimberti VE; Corso G; Dicuonzo S; Rojas DP; Morra A; Gerardi MA; Lorubbio C; Zaffaroni M; Vincini MG; Orecchia R; Jereczek-Fossa BA; Magnoni F
Healthcare (Basel); 2024 Apr; 12(7):. PubMed ID: 38610216
[TBL] [Abstract][Full Text] [Related]
14. What About This IDEA: The PROSPECT That Occult Malignant Lesions May Explain Local Recurrences in Very Early Breast Cancer?
Mann GB; Rose AK; Zdenkowski N
J Clin Oncol; 2024 Jun; 42(16):1997. PubMed ID: 38489564
[No Abstract] [Full Text] [Related]
15. Mammographic surveillance after breast cancer.
Evans A; Dunn J; Donnelly PK
Br J Radiol; 2024 May; 97(1157):882-885. PubMed ID: 38450420
[TBL] [Abstract][Full Text] [Related]
16. Fat necrosis: A consultant's conundrum.
Majithia J; Haria P; Popat P; Katdare A; Chouhan S; Gala KB; Kulkarni S; Thakur M
Front Oncol; 2022; 12():926396. PubMed ID: 36873302
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay.
Lei RY; Carter DL; Antell AG; Nowels MA; Tole SP; Bennett JP; Turner M; Baehner FL; Leonard CE
Adv Radiat Oncol; 2021; 6(2):100607. PubMed ID: 33912731
[TBL] [Abstract][Full Text] [Related]
18. Positive predictive value of biopsy of palpable masses following mastectomy.
Brennan SB; D'Alessio D; Kaplan J; Edelweiss M; Heerdt AS; Morris EA
Breast J; 2018 Sep; 24(5):789-797. PubMed ID: 30033648
[TBL] [Abstract][Full Text] [Related]
19. Effect of surgical wound fluids after intraoperative electron radiotherapy on the cancer stem cell phenotype in a panel of human breast cancer cell lines.
Zaleska K; Suchorska WM; Przybyła A; Murawa D
Oncol Lett; 2016 Nov; 12(5):3707-3714. PubMed ID: 27900058
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
